• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Non-Melanoma Skin Cancer Market Size, Share, Analysis, Opportunities and Forecast 2019 – 2025

July 31st, 2019 BrandEssence Market Research Company Pvt Ltd Releases

Non-Melanoma Skin Cancer Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025-  Increasing prevalence of skin cancer globally is anticipated to drive the growth of Global Non-Melanoma Skin Cancer Market.

Global Non-Melanoma Skin Cancer Market is expected to reach more than USD 659.7 Million by 2025 with a CAGR of 6.2% over the forecast period.

Non-melanoma skin cancer (NMSC) is by far the most frequently diagnosed cancer around the globe. It is also one of the most common occupational diseases in Europe and its prevalence continues to increase. It affects more men than women and is more common in the elderly. It refers to the all types of cancer that occur in the skin which are not melanoma. Sometimes cells in the skin, change and no longer grow normally. These changes may lead to non-cancerous growths such as moles, dermatofibromas, warts and skin tags. But in some cases, these changes can cause non-melanoma skin cancer. It starts in round cells called basal cells and this type of cancer is called basal cell carcinoma (BCC) and makes up about 75%–80% of all skin cancers. It can also start in squamous cells of the skin and this type of cancer is called squamous cell carcinoma (SCC) and makes up about 20% of all skin cancers. Non-melanoma skin cancer treatment depends on the type, size and location of cancer. Surgery is the main treatment for non-melanoma skin cancer which involves the removal of cancerous tumour and some of the surrounding skin. Other treatments include; freezing (cryotherapy), anti-cancer creams, radiotherapy and a form of light treatment called photodynamic therapy (PDT).

Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=72780&RequestType=Sample

Global Non-Melanoma Skin Cancer Market report is segmented on the basis of drug type, application, end-user and region & country level. Based upon drug type, global non-melanoma skin cancer market is classified into radiation therapy, photodynamic therapy and chemotherapy. Radiation therapy is further sub-divided into electronic brachytherapy, external beam radiation therapy and superficial radiation therapy. Based upon application, global non-melanoma skin cancer market is divided into basal cell carcinoma, T-cell lymphoma, squamous cell carcinoma and others. Based on end-user, the non-melanoma skin cancer market is classified into hospitals, specialty clinics and ambulatory surgical centers.

The regions covered in this Global Non-Melanoma Skin Cancer Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of non-melanoma skin cancer is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players for Global Non-Melanoma Skin Cancer Market Report–

Some major key players for Global Non-Melanoma Skin Cancer Market are Almirall S.A., Novartis AG, Mylan NV, Boehringer Ingelheim GmbH, Sensus Healthcare, iCAD, Inc., Accuray, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company, Elekta AB, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd., Varian Medical Systems, Inc., Ion Beam Applications SA and others.

News-

Nicotinamide for Photoprotection and Skin Cancer Chemoprevention: A Review of Efficacy and Safety.

January 30th, 2019; According to a recent review article published in the journal Experimental Dermatology; Nicotinamide offers various photoprotective and anti-inflammatory effects, and phase III evidence now supports its ability to reduce non-melanoma skin cancers and actinic keratoses in high-risk patients. Researchers examined the role of nicotinamide, a water-soluble vitamin B3 derivative that reduces ATP levels and inhibits glycolysis, thereby preventing an energy crisis. They found that randomized controlled clinical trials have demonstrated that nicotinamide limits transepidermal water loss and the growth of non-melanoma skin cancer in high-risk individuals. In addition, they found that patients with normal renal function tolerate nicotinamide well with minimal, if any, side effects, even at doses of about 1 g daily. However, diarrhea was reported among patients on hemodialysis—especially those taking phosphate binders.

Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=72780&RequestType=Methodology

Increasing Prevalence of Skin Cancer Globally, Drives the Growth of Global Non-Melanoma Skin Cancer Market

The major factors driving the growth of global non-melanoma skin cancer market are increasing prevalence of skin cancer and growing awareness regarding its treatment. For example; As per WHO; Currently, between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. According to Skin Cancer Foundation Statistics, one in every five Americans will develop skin cancer in their lifetime. And as per World Cancer Research Fund International; Non-melanoma skin cancer is the 5th most commonly occurring cancer in men and women, with over 1 million diagnosed worldwide in 2018, although this is likely to be an underestimate.

In addition, increasing government funding for research activities and increasing number of clinical trials are also supplementing the growth of the global non-melanoma skin cancer treatment market. Furthermore, improving healthcare infrastructure is also supplementing the growth of the market. However, side-effects of radiation therapy may hamper the global non-melanoma skin cancer treatment market during the forecast period. In spite of that, increasing advancements in the field of innovative products can provide various opportunities for the further growth of the market.

North America is Expected to Dominate the Global Non-Melanoma Skin Cancer Market

The global non-melanoma skin cancer market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America is expected to dominate the global non-melanoma skin cancer market within the forecast period attributed to  the highly developed healthcare infrastructure and increasing cases of non-melanoma skin cancer in this region. For example; As per the American Academy of Dermatology; It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day. Research estimates that non-melanoma skin cancer, including basal cell carcinoma and squamous cell carcinoma, affects more than 3 million Americans a year. In addition, increasing number of cancer treatment centers and presence of leading market players in this region are also supplementing the market growth.

Europe is projected to capture the second largest share of global non-melanoma skin cancer market owing to the increasing prevalence of occupational non-melanoma skin cancer in this region. In the European Union, more than 14.5 million workers are regularly exposed to solar UV radiation for more than 75% of their daily working hours. Occupational skin diseases, which also includes contact dermatitis, are estimated to lead to costs far beyond €5 billion annually in the EU alone.

Asia Pacific is anticipated to witness a significant growth in global non-melanoma skin cancer market owing to the increasing healthcare spending, improving healthcare infrastructure and increasing research and development for new and more effective treatments in this region.

Key Benefits for Global Non-Melanoma Skin Cancer Market Report–

  • Global Non-Melanoma Skin Cancer Market report covers in-depth historical and forecast analysis.
  • Global Non-Melanoma Skin Cancer Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global Non-Melanoma Skin Cancer Market report helps to identify opportunities in marketplace.
  • Global Non-Melanoma Skin Cancer Market report covers extensive analysis of emerging trends and competitive landscape.

Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Non-Melanoma-Skin-Cancer-Market-Size/Summary

Global Non-Melanoma Skin Cancer Market Segmentation: –

By Drug Type:

  • Radiation Therapy
    • Electronic Brachytherapy
    • External Beam Radiation Therapy
    • Superficial Radiation Therapy
  • Photodynamic Therapy
  • Chemotherapy

By Application:

  • Basal Cell Carcinoma
  • T-Cell Lymphoma
  • Squamous Cell Carcinoma
  • Others

By End-User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Regional & Country Level:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

About us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz

Website: https://brandessenceresearch.biz

Related Report:

Medical Devices Industry Reports 2019

Medical Imaging Devices Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Marine Lube Oil Medical Vacuum Regulator Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Medical Film Scanner Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

 

Sign up and submit a press release

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email